Engineered nanomedicine targets liver cancer stem cells to treat liver cancer disease
Journal of Materials Chemistry B · 2025
DOI: 10.1039/d5tb01278c ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Materials Chemistry B, 2025. Verfasst von Fenglan Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China. 15882273316@163.com. Hauptthemen laut MEDLINE: Liver Neoplasms, Neoplastic Stem Cells, Nanomedicine, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 216 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Liver cancer stem cells (LCSCs) are a population of cells with self-renewal and self-differentiation capacities, widely recognized as critical for hepatocellular carcinoma (HCC) development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China. 15882273316@163.com.
- School of Pharmacy, Southwest Minzu University, Chengdu, China.
Zitieren
APA
Huang, F., Chen, L., Zhang, X., Tian, S., Han, Y., Hu, M., He, L., & Luo, R. (2025). Engineered nanomedicine targets liver cancer stem cells to treat liver cancer disease. Journal of Materials Chemistry B. https://doi.org/10.1039/d5tb01278c
Vancouver
Huang F, Chen L, Zhang X, Tian S, Han Y, Hu M, et al. Engineered nanomedicine targets liver cancer stem cells to treat liver cancer disease. Journal of Materials Chemistry B. 2025. doi:10.1039/d5tb01278c
BibTeX
@article{Huang2025,
author = {Huang, Fenglan and Chen, Li and Zhang, Xin and Tian, Shengqian and Han, Yuxin and Hu, Minghui and He, Lili and Luo, Rong},
title = {Engineered nanomedicine targets liver cancer stem cells to treat liver cancer disease},
journal = {Journal of Materials Chemistry B},
year = {2025},
doi = {10.1039/d5tb01278c}
}
EUVIMED